Clinical trial Recruiting at 1 site Interventional Ages 20 and up

Training to improve balance after stroke

Official title: Optimal Intensity of Reactive Balance Training Post-stroke: a Randomized Controlled Trial

Run by Toronto Rehabilitation Institute · NCT06555016 · Data updated 2026-11-12

This study is testing whether higher intensity balance training can help stroke survivors improve their balance and reduce their risk of falling faster than lower intensity training.

Quick facts

Study typeInterventional
Ages20 Years and up
SexAll
Enrollment63 (estimated)
SponsorToronto Rehabilitation Institute
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedNovember 11, 2024
Main results expectedJune 2027
Study endsJune 2028
Registry record updatedOctober 1, 2026
Trial IDNCT06555016 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals who are more than six months post-stroke and can stand and walk independently.

Probably not a fit

Patients who have severe cognitive impairments, other neurological conditions affecting balance, or those currently receiving physiotherapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of reactive balance training (RBT) in improving balance control and reducing fall risk in individuals who have experienced a stroke. The research aims to determine if higher intensity RBT can yield quicker improvements in balance reactions compared to lower intensity training. Participants will engage in exercises designed to challenge their balance through repeated perturbations, with the goal of enhancing their ability to react to loss of balance. The study will also explore how different training intensities affect the outcomes of balance training in stroke survivors.

Why it matters

Potential benefit: If successful, this study could significantly reduce the risk of falls in stroke survivors, improving their overall safety and quality of life.

How similar studies have gone: Previous studies have shown that reactive balance training can reduce fall rates in older adults and those with neurological conditions, suggesting potential success for this approach in stroke rehabilitation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Chronic stroke (\>6 months post-stroke)

Exclusion Criteria:

* Are unable to stand independently without upper-limb support for \>30 seconds and/or walk independently (without a gait aid) for ≥10 metres;
* Have another neurological condition that could affect balance control (e.g., Parkinson's disease);
* Have cognitive impairment (Montreal Cognitive Assessment8 score \<26), or severe language or communication difficulties affecting understanding instructions;
* Have contraindications to RBT (has described by Mansfield et al., 2021), such as osteoporosis, activity restrictions due to cardiac event/surgery, or severe spasticity in the lower extremity; and/or
* Are currently attending in- or out-patient physiotherapy or supervised exercise.

Where it's running

  • Toronto Rehabilitation Institute
    Toronto, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Avril Mansfield, PhD — University Health Network, Toronto
  • Study coordinator: Avril Mansfield, PhD
  • Email: avril.mansfield@uhn.ca
  • Phone: 416-597-3422

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.